It's a parting shot at Wall Street by the Michigan Democrat, who is retiring next month.» Read More
After two insider-trading convictions were overturned, one trader said: "It’s a lot easier to cheat when you know what the rules are."
SEC Chair Mary Jo White says a landmark ruling that threw out two insider trading convictions is an "overly narrow view" of the law.
An appellate court decision significantly redefined insider trading, and may have altered the course of all further enforcement.
SEC chair Mary Jo White weighs in on yesterday's insider trading decision, reports CNBC's Kate Kelly.
Anthony Chaisson's attorney, Gregory Morvillo, Morvillo, LLC partner, shares his thoughts on the insider trading law.
CNBC's Kate Kelly takes a look at the possible repercussion on Wall Street after a Federal appeals court overturned two insider trading convictions.
A U.S. court vacated the insider trading convictions of former hedge fund managers Todd Newman and Anthony Chiasson.
U.S. Attorney Preet Bharara spoke out on the overturning of insider trading convictions. Stephen Fishbein, Shearman and Sterling, offers his response.
CNBC's Michelle Caruso-Cabrera, Brian Sullivan, Ron Insana, and Kate Kelly discuss the ramifications of a federal appeals court overturning the insider trading convictions of Todd Newman and Anthony Chiasson.
CNBC's David Faber provides the latest on the decision by a New York appeals court to vacate the convictions of former hedge fund managers Todd Newman and Anthony Chiasson. Kate Kelly discusses how the ruling may impact the case of Michael Steinberg.
Mark Cuban, once the target of a big U.S. insider trading probe, met publicly with Christopher Cox, the former SEC chairman, for the first time.
CNBC's Brain Sullivan reports two insider trading convictions have been overturned by an appeals court in New York. Jim Cramer and David Faber provide insight.
Former SAC portfolio manager Mathew Martoma has been denied bail, and will serve 9 years in prison, reports CNBC's Brian Sullivan.
CNBC's David Faber reports Valeant Pharmaceuticals is willing to increase its bid for Allergan to at least $200 a share. Jim Cramer provides insight to litigation against investor Bill Ackman over insider trading
Patrick Radden Keefe, The New Yorker staff writer, provides insight to his interview with Rosemary Martoma, the wife of Mathew Martoma about her husband's 9 year prison sentence for insider trading while at Steve Cohen's former hedge fund SAC Capital.
The SEC accuses two men of insider trading ahead of Bill Ackman's announcement that his Pershing Square fund had taken a short position on Herbalife.
CNBC's Scott Wapner reports the SEC has charged two men with insider trading in Herbalife shares. One of the charged men was the roommate of a former Pershing Square analyst.
A month after bolting from court barefoot, New York investor relations executive Michael Lucarelli pleads guilty on his 52nd birthday.
Banned ImClone founder Sam Waksal's new biotech company, Kadmon, has plans to go public. The company aims to file with the SEC by the end of this year.
Dmitry Braverman is the second employee of the Wilson Sonsini law firm to be accused of insider trading in recent years.